Application Value of Targeted Nursing Based on Risk Assessment Strategies in the Treatment of Patients With Gynecological Endocrine Disorders

NCT07004062 | Completed

• 1 other identifier: No.20230815
• Study Type: interventional
• Target: 154
• Locations: 1 country
• Sites: 1

Brief Summary

Risk-based targeted nursing significantly enhances clinical outcomes, quality of life, and mental health in patients with gynecological endocrine disorders, supporting its broader clinical application.

Conditions

Gynecological Endocrine Disorders; Risk Assessment; Targeted Nursing Care; Psychological Support; Quality of Life

Outcome Measures

Primary Outcomes (1)

• Clinical Efficacy of Targeted Nursing in Gynecological Endocrine Disorders

  Proportion of patients achieving significant improvement in endocrine symptoms (e.g., menstrual regularity, hormonal balance) post-intervention, assessed via physician evaluation and laboratory markers (e.g., LH/FSH ratio, testosterone levels).

  Baseline to 6 months post-intervention.

Secondary Outcomes (1)

• Patient Satisfaction with Nursing Care

  End of intervention (Week 12).

Other Outcomes (1)

• Adherence to Lifestyle Interventions

  Weekly during intervention (Weeks 1-12).

Study Arms (2)

control group

OTHER

In the control group, patients received routine nursing care, which primarily involved regular monitoring of vital signs such as blood pressure, temperature, pulse, and respiration. Basic health education was provided, focusing on lifestyle guidance including dietary control and daily routine recommendations. General psychological support was offered through emotional soothing and communicative care to alleviate anxiety. Medication management was strictly implemented in accordance with medical orders to ensure accurate drug administration. In addition, basic daily nursing operations were performed, including assistance with personal hygiene, regular turning to prevent pressure sores, and therapeutic massage when necessary.

Other: Structured Risk Assessment-Based Targeted Nursing Intervention

observation group

EXPERIMENTAL

Patients in the observation group, on the other hand, received targeted nursing interventions based on a structured risk assessment strategy in addition to routine care. This included a comprehensive individualized health assessment that evaluated the patient's lifestyle, dietary habits, stress levels, sleep quality, medical history, and level of social support, leading to the formulation of a personalized nursing plan. Emotional and psychological support was intensified for patients experiencing emotional instability, employing interventions such as cognitive-behavioral therapy, relaxation training, and stress management techniques. Lifestyle interventions were also enhanced by guiding patients to establish regular routines, adopt low-sugar and high-fiber diets rich in vitamins, and engage in appropriate physical activity. Professional nursing interventions were applied to patients with menstrual irregularities or fertility-related needs, including ovulation monitoring and reproducti

Other: Structured Risk Assessment-Based Targeted Nursing Intervention

Interventions

Structured Risk Assessment-Based Targeted Nursing Intervention OTHER

Comprehensive Risk Assessment: Evaluation of lifestyle factors (diet, exercise, sleep), psychosocial stressors, medical history, and endocrine-specific biomarkers Personalized Care Plan: Tailored interventions addressing identified risk factors Psychological Component: Cognitive-behavioral techniques and stress management Lifestyle Modification: Guided nutrition (low-glycemic, high-fiber diet) and physical activity plans Reproductive Health Support: Menstrual cycle monitoring and fertility-related counseling

control group; observation group

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Clinical diagnosis of gynecological endocrine disorder
• Aged 18-45 years
• Complete clinical data available
• Willing and able to provide informed consent

You may not qualify if:

• Severe systemic or psychiatric illness
• Recent major surgery or hormonal/fertility treatment (within 3 months)
• Known hypersensitivity to study medications
• Currently pregnant or breastfeeding
• Participation in another clinical trial within 6 months

Sponsors & Collaborators

• Obstetrics and Gynecology Hospital of Fudan University-Huangpu Campus: lead

Study Sites (1)

Obstetrics and Gynecology Hospital of Fudan University

Shanghai, Shanghai Municipality, 200443, China

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 15, 2025
• First Posted: June 4, 2025
• Study Start: December 15, 2023
• Primary Completion: June 7, 2024
• Study Completion: June 27, 2024
• Last Updated: June 4, 2025

Record last verified: 2023-12

Locations

CN (1)